ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
9.05
-0.01 (-0.11%)
At close: Mar 9, 2026, 4:00 PM EDT
9.23
+0.18 (1.99%)
After-hours: Mar 9, 2026, 5:28 PM EDT
ARS Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 895 | 1,152 | 1,025 | 526 | 800 | - | |
| Market Cap Growth | -21.86% | 12.32% | 94.90% | -34.23% | - | - | |
| Enterprise Value | 746 | 1,033 | 821 | 284 | 839 | - | |
| Last Close Price | 9.06 | 11.65 | 10.55 | 5.48 | 8.53 | - | |
| PE Ratio | - | - | 128.20 | - | - | - | |
| PS Ratio | 10.61 | 13.66 | 11.50 | 17535.50 | 607.80 | - | |
| PB Ratio | 7.87 | 10.08 | 3.99 | 2.28 | 2.93 | - | |
| P/TBV Ratio | 8.96 | 11.54 | 4.12 | 2.29 | 2.93 | - | |
| P/FCF Ratio | - | - | 78.96 | - | - | - | |
| P/OCF Ratio | - | - | 75.68 | - | - | - | |
| EV/Sales Ratio | 8.85 | 12.26 | 9.21 | 9483.00 | 637.20 | - | |
| EV/FCF Ratio | - | - | 63.20 | - | - | - | |
| Debt / Equity Ratio | 0.84 | 0.84 | 0.27 | 0.00 | 0.00 | 0.20 | |
| Debt / FCF Ratio | - | - | 5.35 | - | - | - | |
| Net Debt / Equity Ratio | -1.30 | -1.30 | -0.95 | -0.99 | -1.00 | -1.14 | |
| Net Debt / EBITDA Ratio | 0.84 | 0.84 | 81.42 | 3.38 | 7.96 | 2.65 | |
| Net Debt / FCF Ratio | 0.87 | 0.87 | -18.84 | 3.84 | 6.80 | 2.90 | |
| Asset Turnover | 0.25 | 0.25 | 0.31 | 0 | 0.01 | 0.13 | |
| Inventory Turnover | 3.01 | 3.01 | - | - | - | - | |
| Quick Ratio | 6.91 | 6.91 | 13.79 | 95.80 | 50.59 | 7.34 | |
| Current Ratio | 7.28 | 7.28 | 14.26 | 96.92 | 51.01 | 7.42 | |
| Return on Equity (ROE) | -92.33% | -92.33% | 3.28% | -21.59% | -21.84% | -77.93% | |
| Return on Assets (ROA) | -33.05% | -33.05% | -0.66% | -16.40% | -12.56% | -27.68% | |
| Return on Invested Capital (ROIC) | - | - | -40.01% | -8134.94% | - | - | |
| Return on Capital Employed (ROCE) | -62.20% | -62.20% | -0.90% | -29.30% | -12.50% | -36.50% | |
| Earnings Yield | -19.15% | -14.88% | 0.78% | -10.33% | -4.34% | - | |
| FCF Yield | -19.14% | -14.87% | 1.27% | -11.30% | -5.04% | - | |
| Buyback Yield / Dilution | 3.74% | 3.74% | -7.54% | -138.30% | -38.39% | -42.81% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.